Colorectal Cancer

Latest News

Although trilaciclib appears to reduce neutropenia in patients treated with FOLFOXIRI and bevacizumab in patients with metastatic colorectal cancer, the phase 3 PRESERVE 1 trial will be stopped due to a lack of responses.
Trilaciclib Reduces Neutropenia but Fails to Improve ORR in Metastatic CRC

February 13th 2023

Although trilaciclib appears to reduce neutropenia following treatment with FOLFOXIRI and bevacizumab in patients with metastatic colorectal cancer, the phase 3 PRESERVE 1 trial will be stopped due to a lack of responses.

Recap: Review of Molecular Testing Options in Metastatic Colorectal Cancer
Recap: Review of Molecular Testing Options in Metastatic Colorectal Cancer

February 4th 2023

Findings from the phase 3 BREAKWATER study indicate that encorafenib plus cetuximab and chemotherapy produces activity and is well-tolerated in metastatic colorectal cancer harboring BRAF V600E mutations.
Encorafenib Combo Yields Promising Activity in BRAF V600E-Mutant mCRC

January 24th 2023

Findings from the phase 2 MOUNTAINEER trial indicate that HER2 scoring algorithms may help in identifying which patients are suitable to receive tucatinib plus trastuzumab for metastatic colorectal cancer.
Scoring Algorithms Demonstrate Utility in Screening for Optimal Treatment for HER2+ mCRC

January 23rd 2023

Findings from the phase 3 SUNLIGHT study highlight favorable overall survival and disease control rates with the use of bevacizumab plus trifluridine and tipiracil in metastatic colorectal cancer.
Bevacizumab Combo Yields Survival, DCR Benefits in mCRC

January 23rd 2023

Latest CME Events & Activities

Community Practice Connections™: Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers

View More

2nd Annual Virtual Tumor Board®: Integrating Emerging Testing Methodologies into Optimal Treatment Planning in Gastrointestinal Cancers

View More

Community Practice Connections™: 19th Annual Meeting of the International Society of Gastrointestinal Oncology®

View More

20th Annual Meeting of the International Society of Gastrointestinal Oncology®

10/13/2023-10/14/2023

View More

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

Clinical Vignettes: 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

View More

Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care

View More

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

View More

Medical Crossfire®: Multidisciplinary Strategies to Leverage Clinical Advances on Immune-Based Therapies for Patients with Hepatocellular Carcinoma

View More

8th Annual School of Gastrointestinal Oncology® (SOGO®)

05/06/23 8:00 AM – 5:00 PM EDT

View More

Expert Illustrations & Commentaries™: Targeting FGFR2b Overexpression in Advanced Gastric and GEJ Cancers

View More

Community Practice Connections™: Analyzing the Evolving Role of Liquid Biopsies Across Cancer Care

View More

Clinical Vignettes™: Testing and Treatment Strategies in Cholangiocarcinoma

View More

Advances In™: The Role of NRG1 Fusions Across Tumor Types

View More

Expert Illustrations & Commentaries™: The Role of B7-H3 Across Tumor Types and How It Could Impact Your Practice in the Future

View More

Community Practice Connections™: 7th Annual School of Gastrointestinal Oncology®

View More

Addressing Racial and Ethnic Disparities in Breast Cancer Care: Improving Outcomes Across the Spectrum of Diagnosis, Trial Access, and Patient Care

View More

More News